RNA Outsourcing Resources

1. Enabling CDMOs To Focus On Core Priorities 4/26/2024

   Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.

2. Integrated Solutions For Advanced Therapies

   The right CDMO offering integrated services can ease increasingly common CGT manufacturing problems such as scale, raw material access, viral vector production, and quality requirements.

3. Moving CGTx Clinical Development Forward In 2023 6/27/2023

   Gain insights on cell and gene therapy (CGTx) clinical trial design and commercialization strategies as a panel of industry experts share their considerations.

4. Learn How Compliance-Ready LC-MS Workflows for Oligonucleotides Can Expand your Analytical Services Portfolio 2/22/2022

   CMO invests in solution to ensure data integrity and meet regulatory requirements as they expand their oligonucleotide manufacturing and analysis services.

5. How Outsourcing RNA-LNP Production Can Have A Competitive Advantage 2/23/2023

   Manufacturing RNA-containing LNPs demands specialized expertise  Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.

6. Gene And Cell Therapy: Planning For Manufacturing Success Early 1/16/2023

   As gene therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations, explore how to optimize plasmid production and reach patients with efficiency.

7. Cell And Virus Banking In OV Development And Manufacturing 5/14/2024

   Delve into the exciting potential of OVs, including the critical role of cell and virus seed banks, and discover key considerations for establishing cell and virus banks for OV production.

8. Tackling Antimicrobial Resistance 5/14/2024

   Learn how three companies collaborated to develop and new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.

9. Accelerated Development: Gene Therapy Vs. Small Molecule 12/26/2023

   Combined with the inherent difficulty of the chemistry behind gene therapy development, its pace, structure, and funding dynamics are unique among treatment modalities.

10. Expertise In RNA Therapies: Client Success Stories 2/17/2023

    Learn how to navigate the complex challenges of accelerating therapies through clinical development to regulatory approval and commercialization.